Marshall Wace’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $956K | Buy |
257,620
+99,332
| +63% | +$369K | ﹤0.01% | 1751 |
|
|
2025
Q1 | $511K | Buy |
158,288
+105,544
| +200% | +$341K | ﹤0.01% | 1959 |
|
|
2024
Q4 | $294K | Sell |
52,744
-112,449
| -68% | -$626K | ﹤0.01% | 2090 |
|
|
2024
Q3 | $1.79M | Sell |
165,193
-20,673
| -11% | -$223K | ﹤0.01% | 1302 |
|
|
2024
Q2 | $3.9M | Sell |
185,866
-71,880
| -28% | -$1.51M | 0.01% | 1004 |
|
|
2024
Q1 | $8.21M | Buy |
+257,746
| New | +$8.21M | 0.01% | 713 |
|
|
2023
Q2 | – | Sell |
-33,954
| Closed | -$584K | – | 2155 |
|
|
2023
Q1 | $584K | Sell |
33,954
-35,793
| -51% | -$615K | ﹤0.01% | 1594 |
|
|
2022
Q4 | $1.55M | Buy |
+69,747
| New | +$1.55M | ﹤0.01% | 1445 |
|
|
2022
Q1 | – | Sell |
-3,317
| Closed | -$73K | – | 2816 |
|
|
2021
Q4 | $73K | Buy |
+3,317
| New | +$73K | ﹤0.01% | 2767 |
|
|
2021
Q2 | – | Sell |
-18,760
| Closed | -$814K | – | 2228 |
|
|
2021
Q1 | $814K | Buy |
18,760
+11,324
| +152% | +$491K | ﹤0.01% | 1481 |
|
|
2020
Q4 | $308K | Buy |
+7,436
| New | +$308K | ﹤0.01% | 1510 |
|